These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38912931)

  • 41. Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study.
    Chinnadurai R; Flanagan E; Jayson GC; Kalra PA
    BMC Nephrol; 2019 Oct; 20(1):380. PubMed ID: 31640599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adherence to Kidney Disease: Improving Global Outcomes Mineral and Bone Guidelines for Monitoring Biochemical Parameters.
    Roetker NS; Peng Y; Ashfaq A; Gilbertson DT; Wetmore JB
    Am J Nephrol; 2019; 49(3):225-232. PubMed ID: 30820015
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence, socio-demographic characteristics, and comorbid health conditions in pre-dialysis chronic kidney disease: results from the Manitoba chronic kidney disease cohort.
    Chartier MJ; Tangri N; Komenda P; Walld R; Koseva I; Burchill C; McGowan KL; Dart A
    BMC Nephrol; 2018 Oct; 19(1):255. PubMed ID: 30305038
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A contemporary evaluation of carotid endarterectomy outcomes in patients with chronic kidney disease in the United States.
    Patel AR; Dombrovskiy VY; Vogel TR
    Vascular; 2017 Oct; 25(5):459-465. PubMed ID: 28181855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improving care coordination between nephrology and primary care: a quality improvement initiative using the renal physicians association toolkit.
    Haley WE; Beckrich AL; Sayre J; McNeil R; Fumo P; Rao VM; Lerma EV
    Am J Kidney Dis; 2015 Jan; 65(1):67-79. PubMed ID: 25183380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Economic and Clinical Outcomes Resulting From the Stage 4 Chronic Kidney Disease Case Management Quality Improvement Initiative.
    Everett B; Castel LD; McGinnis M; Beresky A; Cane RC; Cooper T; Davda RK; Farmer D; John SM; Sollars DL; Rausch JF
    Prof Case Manag; 2017; 22(6):291-298. PubMed ID: 28902768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population.
    Chung H; Crowe CL; Kong SX; Singh R; Farej R; Elliott J; Williamson T; Willey VJ
    J Manag Care Spec Pharm; 2023 Jan; 29(1):80-89. PubMed ID: 36580126
    [No Abstract]   [Full Text] [Related]  

  • 48. The social cost of chronic kidney disease in Italy.
    Turchetti G; Bellelli S; Amato M; Bianchi S; Conti P; Cupisti A; Panichi V; Rosati A; Pizzarelli F;
    Eur J Health Econ; 2017 Sep; 18(7):847-858. PubMed ID: 27699568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.
    Lundström UH; Gasparini A; Bellocco R; Qureshi AR; Carrero JJ; Evans M
    BMC Nephrol; 2017 Feb; 18(1):59. PubMed ID: 28187786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation study of medicare claims to identify older US adults with CKD using the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
    Muntner P; Gutiérrez OM; Zhao H; Fox CS; Wright NC; Curtis JR; McClellan W; Wang H; Kilgore M; Warnock DG; Bowling CB
    Am J Kidney Dis; 2015 Feb; 65(2):249-58. PubMed ID: 25242367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effective treatment modalities for reducing morbidity associated with chronic kidney disease.
    Ferguson TW; Tangri N; Rigatto C; Komenda P
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):243-52. PubMed ID: 25661187
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Healthcare utilization and cost burden of Huntington's disease among Medicare beneficiaries in the United States.
    Exuzides A; Reddy SR; Chang E; Ta JT; Patel AM; Paydar C; Yohrling GJ
    J Med Econ; 2021; 24(1):1327-1336. PubMed ID: 34730477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute Kidney Injury Recovery Pattern and Subsequent Risk of CKD: An Analysis of Veterans Health Administration Data.
    Heung M; Steffick DE; Zivin K; Gillespie BW; Banerjee T; Hsu CY; Powe NR; Pavkov ME; Williams DE; Saran R; Shahinian VB;
    Am J Kidney Dis; 2016 May; 67(5):742-52. PubMed ID: 26690912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Referral and comanagement of the patient with CKD.
    Campbell GA; Bolton WK
    Adv Chronic Kidney Dis; 2011 Nov; 18(6):420-7. PubMed ID: 22098660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patient characteristics and initiation of mineralocorticoid receptor antagonists in patients with chronic kidney disease in routine clinical practice in the US: a retrospective cohort study.
    Blankenburg M; Fett AK; Eisenring S; Haas G; Gay A
    BMC Nephrol; 2019 May; 20(1):171. PubMed ID: 31096928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-Need Phenotypes in Medicare Beneficiaries: Drivers of Variation in Utilization and Outcomes.
    Keeney T; Belanger E; Jones RN; Joyce NR; Meyers DJ; Mor V
    J Am Geriatr Soc; 2020 Jan; 68(1):70-77. PubMed ID: 31454082
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
    Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
    BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nephrology Referral Based on Laboratory Values, Kidney Failure Risk, or Both: A Study Using Veterans Affairs Health System Data.
    Duggal V; Montez-Rath ME; Thomas IC; Goldstein MK; Tamura MK
    Am J Kidney Dis; 2022 Mar; 79(3):347-353. PubMed ID: 34450193
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Managing the burden of chronic kidney disease.
    Thorp ML; Eastman L; Smith DH; Johnson ES
    Dis Manag; 2006 Apr; 9(2):115-21. PubMed ID: 16620197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of multiple chronic conditions in the United States' Medicare population.
    Schneider KM; O'Donnell BE; Dean D
    Health Qual Life Outcomes; 2009 Sep; 7():82. PubMed ID: 19737412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.